Filters
Other countries
Results: 1 to 15 of 15
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
OnkoRisk Hereditary Oncology Management Panel BioReference Health United States | 47 | 17 |
|
OnkoRisk Hereditary Oncology Guideline Panel BioReference Health United States | 71 | 54 |
|
RNASEL - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
IntelligeneCG LLC United States | 3 | 14 |
|
Color Diagnostics, LLC DBA Color Health United States | 51 | 59 |
|
Prostate Cancer NGS panel (germeline analysis) CIBIC S.A. Argentina | 1 | 18 |
|
Prostate Cancer NGS panel (somatic analysis) CIBIC S.A. Argentina | 1 | 18 |
|
Hereditary Prostate Cancer Panel GeneDx United States | 28 | 16 |
|
Breast Cancer Management Panel GeneDx United States | 24 | 9 |
|
Asper Biogene Asper Biogene LLC Estonia | 25 | 13 |
|
Familial Prostate Cancer , Panel Massive Sequencing (NGS) 11 Genes Reference Laboratory Genetics Spain | 8 | 11 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 1103 | 676 |
|
Results: 1 to 15 of 15
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.